STABILIZED PRE-FUSION PIV3 F PROTEINS

The present invention relates to stabilized pre-fusion human parainfluenza virus 3 (HPIV3) F protein, and fragments thereof. The invention also relates to nucleic acid molecules encoding such proteins and fragments, and to the use of the proteins, fragments and nucleic acid molecules. La presente in...

Full description

Saved in:
Bibliographic Details
Main Authors LANGEDIJK Johannes Petrus Maria, BAKKERS Mark Johannes Gerardus, JURASZEK Jaroslaw, RITSCHEL Tina
Format Patent
LanguageEnglish
Spanish
Published 13.10.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to stabilized pre-fusion human parainfluenza virus 3 (HPIV3) F protein, and fragments thereof. The invention also relates to nucleic acid molecules encoding such proteins and fragments, and to the use of the proteins, fragments and nucleic acid molecules. La presente invención se relaciona con la proteína estabilizada del virus de parainfluenza humana 3 (HPIV3) F prefusión, y fragmentos de esta. La invención también se relaciona con moléculas de ácido nucleico que codifican tales proteínas y fragmentos, y al uso de las proteínas, fragmentos y moléculas de ácido nucleico.
Bibliography:Application Number: MX20230011629